chr1-235663082-TA-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_000081.4(LYST):​c.11268-5delT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.55 ( 24874 hom., cov: 0)
Exomes 𝑓: 0.45 ( 44544 hom. )
Failed GnomAD Quality Control

Consequence

LYST
NM_000081.4 splice_region, intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13O:1

Conservation

PhyloP100: -0.694

Publications

6 publications found
Variant links:
Genes affected
LYST (HGNC:1968): (lysosomal trafficking regulator) This gene encodes a protein that regulates intracellular protein trafficking in endosomes, and may be involved in pigmentation. Mutations in this gene are associated with Chediak-Higashi syndrome, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants, though the full-length nature of some of these variants has not been determined. [provided by RefSeq, Apr 2013]
LYST Gene-Disease associations (from GenCC):
  • Chediak-Higashi syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • attenuated Chédiak-Higashi syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 1-235663082-TA-T is Benign according to our data. Variant chr1-235663082-TA-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 403065.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.766 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LYSTNM_000081.4 linkc.11268-5delT splice_region_variant, intron_variant Intron 52 of 52 ENST00000389793.7 NP_000072.2 Q99698-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LYSTENST00000389793.7 linkc.11268-5delT splice_region_variant, intron_variant Intron 52 of 52 5 NM_000081.4 ENSP00000374443.2 Q99698-1

Frequencies

GnomAD3 genomes
AF:
0.553
AC:
82566
AN:
149220
Hom.:
24831
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.773
Gnomad AMI
AF:
0.487
Gnomad AMR
AF:
0.390
Gnomad ASJ
AF:
0.487
Gnomad EAS
AF:
0.0495
Gnomad SAS
AF:
0.177
Gnomad FIN
AF:
0.549
Gnomad MID
AF:
0.497
Gnomad NFE
AF:
0.526
Gnomad OTH
AF:
0.525
GnomAD2 exomes
AF:
0.508
AC:
82886
AN:
163066
AF XY:
0.508
show subpopulations
Gnomad AFR exome
AF:
0.681
Gnomad AMR exome
AF:
0.448
Gnomad ASJ exome
AF:
0.517
Gnomad EAS exome
AF:
0.239
Gnomad FIN exome
AF:
0.530
Gnomad NFE exome
AF:
0.534
Gnomad OTH exome
AF:
0.512
GnomAD4 exome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.451
AC:
505703
AN:
1122018
Hom.:
44544
Cov.:
0
AF XY:
0.451
AC XY:
251328
AN XY:
557718
show subpopulations
African (AFR)
AF:
0.582
AC:
14906
AN:
25598
American (AMR)
AF:
0.389
AC:
12497
AN:
32128
Ashkenazi Jewish (ASJ)
AF:
0.469
AC:
9746
AN:
20776
East Asian (EAS)
AF:
0.190
AC:
4370
AN:
22946
South Asian (SAS)
AF:
0.315
AC:
17610
AN:
55940
European-Finnish (FIN)
AF:
0.504
AC:
22250
AN:
44118
Middle Eastern (MID)
AF:
0.448
AC:
2031
AN:
4536
European-Non Finnish (NFE)
AF:
0.462
AC:
400966
AN:
868486
Other (OTH)
AF:
0.449
AC:
21327
AN:
47490
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
13920
27840
41759
55679
69599
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13180
26360
39540
52720
65900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.554
AC:
82650
AN:
149304
Hom.:
24874
Cov.:
0
AF XY:
0.540
AC XY:
39239
AN XY:
72718
show subpopulations
African (AFR)
AF:
0.774
AC:
31731
AN:
41020
American (AMR)
AF:
0.390
AC:
5786
AN:
14854
Ashkenazi Jewish (ASJ)
AF:
0.487
AC:
1667
AN:
3426
East Asian (EAS)
AF:
0.0497
AC:
251
AN:
5054
South Asian (SAS)
AF:
0.176
AC:
822
AN:
4678
European-Finnish (FIN)
AF:
0.549
AC:
5432
AN:
9898
Middle Eastern (MID)
AF:
0.504
AC:
141
AN:
280
European-Non Finnish (NFE)
AF:
0.526
AC:
35295
AN:
67112
Other (OTH)
AF:
0.522
AC:
1085
AN:
2078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1623
3246
4868
6491
8114
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
670
1340
2010
2680
3350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.430
Hom.:
1207
Bravo
AF:
0.553

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:13Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 44% of patients studied by a panel of primary immunodeficiencies. Number of patients: 42. Only high quality variants are reported. -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Chédiak-Higashi syndrome Benign:5
May 04, 2023
Molecular Genetics, Royal Melbourne Hospital
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

African/African American population allele frequency is 66.84% (rs767372373, 14,577/20,186 alleles, 4,812 homozygotes in gnomAD v2.1). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.1.0, this variant is classified as BENIGN. Following criteria are met: BA1 -

Oct 09, 2014
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 09, 2014
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 11, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2Other:1
-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 22, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27781387, 29357941) -

Autoinflammatory syndrome Benign:1
Dec 01, 2019
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.69
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs36014994; hg19: chr1-235826382; COSMIC: COSV67710885; API